Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
Introduction and aim. Epigenetic alterations play an essential role in cancer onset and progression, thus studies of drugs targeting the epigenetic machinery are a principal concern for cancer treatment. Here, we evaluated the potential of the DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine (...
Main Authors: | Diego Uribe, Andres Cardona, Davide Degli Esposti, Marie-Pierre Cros, Cyrille Cuenin, Zdenko Herceg, Mauricio Camargo, Fabian M. Cortés-Mancera |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-05-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119302005 |
Similar Items
-
DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis
by: Yonghwan Shin, et al.
Published: (2019-04-01) -
Epigenetic Silencing of DKK3 in Medulloblastoma
by: André Oberthuer, et al.
Published: (2013-04-01) -
Tumor suppressor gene E-cadherin and its role in normal and malignant cells
by: Pećina-Šlaus Nives
Published: (2003-10-01) -
Expression Levels of E-cadherin in Breast Cancer Cells Alter Apoptotic Susceptibility and Facilitate Cancer Stem Cell Phenotypes in Response to Wnt Signalling
by: Ooi, Sarah
Published: (2015) -
Activation of expression of p15, p73 and E-cadherin in myeloid leukemia cells by different concentrations of 5-aza-2'-deoxycytidine
by: Farinha, Nuno Jorge dos Reis
Published: (2016)